PHARMACYTE BIOTECH, INC. (PMCB) Operating income 2017–2026
PHARMACYTE BIOTECH, INC. (PMCB) annual operating income history from SEC filings — each fiscal year as reported.
-$6.9MFY2026 · since FY2017: -$4.4M → -$6.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$6.9M | -56.6% |
| FY2025 | -$4.4M | +48.6% |
| FY2024 | -$8.5M | -32.0% |
| FY2023 | -$6.5M | -47.0% |
| FY2022 | -$4.4M | -21.2% |
| FY2021 | -$3.6M | +5.3% |
| FY2020 | -$3.8M | +6.7% |
| FY2019 | -$4.1M | +41.3% |
| FY2018 | -$7.0M | -57.2% |
| FY2017 | -$4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice